Earnings Feed
Start Free
$IRD·4

REXAHN PHARMACEUTICALS, INC. · Jan 14, 7:26 PM ET

REXAHN PHARMACEUTICALS, INC. 4

4 · REXAHN PHARMACEUTICALS, INC. · Filed Jan 14, 2014

Insider Transaction Report

Form 4
Period: 2014-01-12
REXAHN PHARMACEUTICALS, INC.RNN
Soni Rakesh
Chief Business Officer
Transactions
  • Award

    Stock Option (right to purchase)

    2014-01-12+85,000→ 85,000 total
    Exercise: $1.14Exp: 2024-01-12→ Common Stock (85,000 underlying)
Holdings

  • Stock Option (right to purchase)

    Exercise: $0.31Exp: 2023-03-01→ Common Stock (50,000 underlying)
    50,000

  • Stock Option (right to purchase)

    Exercise: $1.29Exp: 2018-09-30→ Common Stock (300,000 underlying)
    300,000

  • Common Stock

    2,700

  • Stock Option (right to purchase)

    Exercise: $0.78Exp: 2018-12-11→ Common Stock (250,000 underlying)
    250,000
Footnotes (4)
  • [F1]Options will vest and be exercisable based on the following schedule: 25,500 on January 12, 2015, 25,500 on January 12, 2016, and 34,000 on January 12, 2017.
  • [F2]Options will vest and be exercisable based on the following schedule: 15,000 on March 1, 2014, 15,000 on March 1, 2015, and 20,000 on March 1, 2016.
  • [F3]Options vested and became exercisable based on the following schedule 75,000 on December 11, 2009, 75,000 on December 11, 2010, and 100,000 on December 11, 2011.
  • [F4]Options vested and became exercisable based on the following schedule 90,000 on September 30, 2009, 90,000 on September 30, 2010, and 120,000 on September 30, 2011.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4